BioMed Research International

Research Article

Urinary TWEAK Level as a Marker of Lupus Nephritis Activity in 46 Cases

Table 1

Comparison between active group and nonactive group in terms of important clinical and laboratory findings.
Active Group ( š‘› = 3 4 )
M e a n Ā± S D 		Nonactive Group ( š‘› = 1 2 )
M e a n Ā± S D
Male/female ratio1/333/9
Disease duration of SLE (month) 1 2 . 7 1 Ā± 3 . 3 9 1 7 . 9 9 Ā± 6 . 4 6
Disease duration of LN (month) 8 . 4 4 Ā± 2 . 1 3 1 4 . 0 6 Ā± 4 . 5 5
Red blood cell count in urine (/HP) 6 . 3 6 Ā± 0 . 6 7 1 . 8 8 Ā± 0 . 6 1
24-h urinary proteins (g/24ā€‰hr) 3 3 9 6 Ā± 1 1 0 7 1 1 6 6 Ā± 4 0 8
Serum BUN (mmol/L) 1 0 . 1 3 Ā± 1 . 0 2 7 . 8 4 Ā± 2 . 1 1
Serum Cr (Ī¼mol/L) 1 1 3 . 5 0 Ā± 9 . 2 3 9 2 . 3 6 Ā± 1 9 . 0 9
Serum C3 (mmol/L) 0 . 4 6 Ā± 0 . 0 4 0 . 5 8 Ā± 0 . 0 7
Serum C4 (mmol/L) 0 . 1 0 Ā± 0 . 0 1 0 . 1 4 Ā± 0 . 0 2
SLE: systemic lupus erythematosus; LN: lupus nephritis; BUN: blood urea nitrogen; Cr: creatinine; C3: complement3; C4: complement4.